Search results
Results from the WOW.Com Content Network
The Health Protection (Coronavirus, International Travel) (England) Regulations 2020 (SI 2020/568) is a statutory instrument (SI) made on 2 June 2020 by the Secretary of State for Health and Social Care, Matt Hancock, in response to the COVID-19 pandemic. The regulations aimed to reduce the possibility of infection spreading from travellers ...
The Health Protection (Coronavirus, International Travel and Operator Liability) (England) Regulations 2021 (SI 2021/582) is a statutory instrument (SI) made on 14 May 2021 by the Secretary of State for Health and Social Care, Matt Hancock, in response to the COVID-19 pandemic. The regulations aimed to reduce the possibility of infection ...
COVID-19 vaccination in France started on 27 December 2020 after the approval of Pfizer–BioNTech COVID-19 vaccine by the European Union commission. According to a June 2022 study published in The Lancet , COVID-19 vaccination in France prevented an additional 631,000 deaths from December 8, 2020, to December 8, 2021.
Driving in France. Many of the basic rules for driving in France – other than, cruicially, which side of the road to drive on – are similar to those in the UK. Drivers must be at least 18 ...
During the COVID-19 pandemic, several COVID-19 vaccines were developed, and in December 2020 the first vaccination campaign was planned. [8] Anticipating the vaccine, on 23 November 2020, Qantas announced that the company would ask for proof of COVID-19 vaccination from international travellers. According to Alan Joyce, the firm's CEO, a ...
Context and earlier regulations. The first responses by the UK government to the developing COVID-19 pandemic in England took the form of guidance rather than legislation. . Statements by the prime minister and other ministers included advice to schools to cancel trips abroad (12 March); to the public to avoid non-essential travel, crowded places such as pubs and theatres, mass gatherings, and ...
v. t. e. The Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield[31] and Vaxzevria[1][32] among others, is a viral vector vaccine for the prevention of COVID-19. It was developed in the United Kingdom by Oxford University and British-Swedish company AstraZeneca, [33][34][35] using as a vector the modified chimpanzee ...
v. t. e. The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products. Prior to 2004, it was known as the European Agency for the Evaluation of Medicinal Products or European Medicines Evaluation Agency (EMEA). [4][5] The EMA was set up in 1995, with funding ...